Maternal Anti- Toxoplasma Treatment during Pregnancy Is Associated with Reduced Sensitivity of Diagnostic Tests for Congenital Infection in the Neonate-Reference-Cited by-同舟云学术

Maternal Anti- Toxoplasma Treatment during Pregnancy Is Associated with Reduced Sensitivity of Diagnostic Tests for Congenital Infection in the Neonate

Published:2021-01-21 Issue:2 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Guegan Hélène¹,Stajner Tijana²,Bobic Branko²,Press Cindy³,Olariu Rares T.³⁴,Olson Kjerstie³,Srbljanovic Jelena²,Montoya Jose G.³,Djurković-Djaković Olgica²,Robert-Gangneux Florence¹^ORCID

Affiliation:

1. Université de Rennes, CHU Rennes, Inserm, EHESP, Irset-UMR_S 1085, Rennes, France

2. National Reference Laboratory for Toxoplasmosis, Institute for Medical Research, University of Belgrade, Belgrade, Serbia

3. Dr. Jack S. Remington Laboratory for Specialty Diagnostics, Palo Alto, California, USA

4. Victor Babes University of Medicine and Pharmacy, Timisoara, Romania

Abstract

Neonatal diagnosis of congenital toxoplasmosis is based on a combination of serological and molecular tests. Maternal screening and treatment differ according to national policies and may impact the sensitivity of diagnostic methods in infants at birth.

Funder

Campus France

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01368-20

Reference37 articles.

1. Toxoplasma gondiiin beef consumed in France: regional variation in seroprevalence and parasite isolation

2. Assessing viability and infectivity of foodborne and waterborne stages (cysts/oocysts) of Giardia duodenalis, Cryptosporidium spp., and Toxoplasma gondii: a review of methods